SCHEMBL6465432

SCHEMBL6465432

Cn1c(=O)n(Cc2ccccc2)c(=O)c2c(C(=O)OC(F)(F)C(F)C(F)(F)F)csc21

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ERCC5 P28715 1/20 0.39
FEN1 P39748 1/20 0.39
MEN1 O00255 6/20 0.39
KMT2A Q03164 6/20 0.39
SMN1; SMN2 Q16637 4/20 0.39
LMNA P02545 3/20 0.39
MAPT P10636 3/20 0.39
KDM4E B2RXH2 2/20 0.39
CYP3A4 P08684 1/20 0.39
ADORA2B P29275 1/20 0.38
ALDH1A1 P00352 3/20 0.37
PKM P14618 2/20 0.37
HPGD P15428 1/20 0.37
HSD17B10 Q99714 1/20 0.37
RAB9A P51151 1/20 0.37
TP53 P04637 1/20 0.36
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6465721 0.86 ERCC5 (0.41) ERCC5FEN1MEN1KMT2ASMN1; SMN2
SCHEMBL7101590 0.82 KMT2A (0.43) ERCC5FEN1MEN1KMT2ASMN1; SMN2
SCHEMBL6471284 0.80 MEN1 (0.46) ERCC5FEN1MEN1KMT2ASMN1; SMN2
SCHEMBL6476633 0.80 ALDH1A1 (0.43) ERCC5FEN1MEN1KMT2ASMN1; SMN2
SCHEMBL6472164 0.80 ERCC5 (0.43) ERCC5FEN1MEN1KMT2ASMN1; SMN2
SCHEMBL6724730 0.80 SMN1; SMN2 (0.40) MEN1KMT2ASMN1; SMN2LMNAMAPT
SCHEMBL6255377 0.80 MEN1 (0.52) ERCC5FEN1MEN1KMT2ASMN1; SMN2
SCHEMBL7027372 0.79 ERCC5 (0.42) ERCC5FEN1MEN1KMT2ASMN1; SMN2
SCHEMBL6472338 0.79 MEN1 (0.41) ERCC5FEN1MEN1KMT2ASMN1; SMN2
SCHEMBL6474542 0.79 ADORA2B (0.44) ERCC5FEN1MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1530475-A2 PHARMACEUTICAL COMPOSITIONS COMPRISING AN ALLOSTERIC CARBOXYLIC INHIBITOR OF MATRIX METALLOPROTEINASE-13 AND A SELECTIVE INHIBITOR OF CYCLOOXYGENASE-2 Warner-Lambert Company LLC (US) 2005-05-18 EP disclosed
WO-2004006931-A2 PHARMACEUTICAL COMPOSTIONS COMPRISING AN ALLOSTERIC CARBOXYLIC INHIBITOR OF MATRIX METALLOPROTEINASE-13 AND A SELECTIVE INHIBITOR OF CYCLOOXYGENASE-2 WARNER-LAMBERT COMPANY LLC (US) 2004-01-22 WO disclosed